Cargando…

The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis

BACKGROUND: Aging induced chronic systemic inflammatory response is an important risk factor for atherosclerosis (AS) development; however, the detailed mechanism is yet to be elucidated. OBJECTIVE: To explore the underlying mechanism of how aging aggravates AS advancement. METHODS: A young (five-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yingxin, Wu, Danbin, Zeng, Wenyun, Chen, Yefei, Guo, Maojuan, Lu, Bin, Li, Huhu, Sun, Chun, Yang, Lin, Jiang, Xijuan, Gao, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012722/
https://www.ncbi.nlm.nih.gov/pubmed/33816331
http://dx.doi.org/10.3389/fcimb.2021.618265
_version_ 1783673425673322496
author Sun, Yingxin
Wu, Danbin
Zeng, Wenyun
Chen, Yefei
Guo, Maojuan
Lu, Bin
Li, Huhu
Sun, Chun
Yang, Lin
Jiang, Xijuan
Gao, Qing
author_facet Sun, Yingxin
Wu, Danbin
Zeng, Wenyun
Chen, Yefei
Guo, Maojuan
Lu, Bin
Li, Huhu
Sun, Chun
Yang, Lin
Jiang, Xijuan
Gao, Qing
author_sort Sun, Yingxin
collection PubMed
description BACKGROUND: Aging induced chronic systemic inflammatory response is an important risk factor for atherosclerosis (AS) development; however, the detailed mechanism is yet to be elucidated. OBJECTIVE: To explore the underlying mechanism of how aging aggravates AS advancement. METHODS: A young (five-week-old, YM) and aged group (32-week-old, OM) male apoE(-/-) mice with a high fat diet were used as models, and age-matched male wild-type C57BL/6J (WT) mice were used as controls. AS lesion size, serum lipid profile, cytokines, and gut microbiota-derived LPS were analyzed after 32 weeks of diet intervention. A correlation analysis between the 16S rRNA sequencing of the feces and serum metabolomics profiles was applied to examine the effect of their interactions on AS. RESULTS: ApoE(-/-) mice developed severe atherosclerosis and inflammation in the aorta compared to the WT groups, and aged apoE(-/-) mice suffered from a more severe AS lesion than their younger counterparts and had low-grade systemic inflammation. Furthermore, increased levels of serum LPS, decreased levels of SCFAs production, as well as dysfunction of the ileal mucosal barrier were detected in aged mice compared with their younger counterparts. There were significant differences in the intestinal flora composition among the four groups, and harmful bacteria such as Lachnospiraceae_FCS020, Ruminococcaceae_UCG-009, Acetatifactor, Lachnoclostridium and Lactobacillus_gasseri were significantly increased in the aged apoE(-/-) mice compared with the other groups. Concurrently, metabolomics profiling revealed that components involved in the arachidonic acid (AA) metabolic pathway such as 20-HETE, PGF2α, arachidonic acid, and LTB4 were significantly higher in the aged AS group than in the other groups. This suggested that metabolic abnormalities and disorders of intestinal flora occurred in AS mice. CONCLUSIONS: Aging not only altered the gut microbiome community but also substantially disturbed metabolic conditions. Our results confirm that AA metabolism is associated with the imbalance of the intestinal flora in the AS lesions of aged mice. These findings may offer new insights regarding the role of gut flora disorders and its consequent metabolite changed in inflammaging during AS development.
format Online
Article
Text
id pubmed-8012722
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80127222021-04-02 The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis Sun, Yingxin Wu, Danbin Zeng, Wenyun Chen, Yefei Guo, Maojuan Lu, Bin Li, Huhu Sun, Chun Yang, Lin Jiang, Xijuan Gao, Qing Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Aging induced chronic systemic inflammatory response is an important risk factor for atherosclerosis (AS) development; however, the detailed mechanism is yet to be elucidated. OBJECTIVE: To explore the underlying mechanism of how aging aggravates AS advancement. METHODS: A young (five-week-old, YM) and aged group (32-week-old, OM) male apoE(-/-) mice with a high fat diet were used as models, and age-matched male wild-type C57BL/6J (WT) mice were used as controls. AS lesion size, serum lipid profile, cytokines, and gut microbiota-derived LPS were analyzed after 32 weeks of diet intervention. A correlation analysis between the 16S rRNA sequencing of the feces and serum metabolomics profiles was applied to examine the effect of their interactions on AS. RESULTS: ApoE(-/-) mice developed severe atherosclerosis and inflammation in the aorta compared to the WT groups, and aged apoE(-/-) mice suffered from a more severe AS lesion than their younger counterparts and had low-grade systemic inflammation. Furthermore, increased levels of serum LPS, decreased levels of SCFAs production, as well as dysfunction of the ileal mucosal barrier were detected in aged mice compared with their younger counterparts. There were significant differences in the intestinal flora composition among the four groups, and harmful bacteria such as Lachnospiraceae_FCS020, Ruminococcaceae_UCG-009, Acetatifactor, Lachnoclostridium and Lactobacillus_gasseri were significantly increased in the aged apoE(-/-) mice compared with the other groups. Concurrently, metabolomics profiling revealed that components involved in the arachidonic acid (AA) metabolic pathway such as 20-HETE, PGF2α, arachidonic acid, and LTB4 were significantly higher in the aged AS group than in the other groups. This suggested that metabolic abnormalities and disorders of intestinal flora occurred in AS mice. CONCLUSIONS: Aging not only altered the gut microbiome community but also substantially disturbed metabolic conditions. Our results confirm that AA metabolism is associated with the imbalance of the intestinal flora in the AS lesions of aged mice. These findings may offer new insights regarding the role of gut flora disorders and its consequent metabolite changed in inflammaging during AS development. Frontiers Media S.A. 2021-03-18 /pmc/articles/PMC8012722/ /pubmed/33816331 http://dx.doi.org/10.3389/fcimb.2021.618265 Text en Copyright © 2021 Sun, Wu, Zeng, Chen, Guo, Lu, Li, Sun, Yang, Jiang and Gao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Sun, Yingxin
Wu, Danbin
Zeng, Wenyun
Chen, Yefei
Guo, Maojuan
Lu, Bin
Li, Huhu
Sun, Chun
Yang, Lin
Jiang, Xijuan
Gao, Qing
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
title The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
title_full The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
title_fullStr The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
title_full_unstemmed The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
title_short The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis
title_sort role of intestinal dysbacteriosis induced arachidonic acid metabolism disorder in inflammaging in atherosclerosis
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012722/
https://www.ncbi.nlm.nih.gov/pubmed/33816331
http://dx.doi.org/10.3389/fcimb.2021.618265
work_keys_str_mv AT sunyingxin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT wudanbin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT zengwenyun theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT chenyefei theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT guomaojuan theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT lubin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT lihuhu theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT sunchun theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT yanglin theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT jiangxijuan theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT gaoqing theroleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT sunyingxin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT wudanbin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT zengwenyun roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT chenyefei roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT guomaojuan roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT lubin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT lihuhu roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT sunchun roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT yanglin roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT jiangxijuan roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis
AT gaoqing roleofintestinaldysbacteriosisinducedarachidonicacidmetabolismdisorderininflammaginginatherosclerosis